Publication date: Mar 27, 2025
Our vision is a world of mental wellbeing. Forward-looking statementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. Up to a third of people with depression are failed by multiple attempts at treatment. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Up to two-thirds of people with depression are not helped by the first antidepressant medication they try. Depression is the leading cause of disability and ill health worldwide. “Story ContinuesCompass is headquartered in London, UK, with offices in New York and San Francisco in the US.
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | treatment resistant depression |
| disease | MESH | PTSD |
| pathway | REACTOME | Release |
| disease | MESH | major depressive disorder |
| drug | DRUGBANK | Tropicamide |
| drug | DRUGBANK | Psilocybine |
| disease | MESH | Depression |